Acquiring Company
HLB Innovation
Acquired Company
HLB Cell
Description
HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. By integrating HLB Cell, the company aims to enhance its research and development in regenerative medicine. The move is expected to significantly boost their operational capabilities in this field.
Don't miss HLB Innovation's next move
Get an email the moment HLB Innovation makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired HLB Cell?
HLB Cell was acquired by HLB Innovation, based in South Korea. The deal was reported on September 9, 2026. HLB Innovation is a publicly traded company in South Korea and a member of the HLB Group. HLB Innovation is privately held and operates in Biotechnology.
When did HLB Innovation acquire HLB Cell?
HLB Innovation's acquisition of HLB Cell was reported on September 9, 2026. HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does HLB Cell do?
HLB Cell specializes in cell therapy and regenerative medicine. The company is dedicated to advancing therapeutic options for various diseases. They are known for their research and development in cellular treatments. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.